Register entry

DOTTIKON EXCLUSIVE SYNTHESIS AG

Registered sites
1
Drug products
16
Live patents
0
Countries
1
Base
Switzerland
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Analytical testingActive ingredient (API) manufacture
Sites

Facilities

1
SiteLocationOperationsFEI
DOTTIKON EXCLUSIVE SYNTHESIS AGDottikonSwitzerlandAnalytical testing, Active ingredient (API) manufacture3002806909
Catalogue

Marketed products

16

Showing 16 of 16.

BrandGeneric nameFormCategory
-ACALABRUTINIB MALEATEPOWDERBULK INGREDIENT
-DAPAGLIFLOZIN PROPANEDIOLPOWDERBULK INGREDIENT
-DAPAGLIFLOZIN PROPANEDIOLPOWDERBULK INGREDIENT
-DAPAGLIFLOZIN PROPANEDIOLPOWDERBULK INGREDIENT
-DAPAGLIFLOZIN PROPANEDIOLPOWDERBULK INGREDIENT
-DAPAGLIFLOZIN PROPANEDIOLPOWDERBULK INGREDIENT
-DAPAGLIFLOZIN PROPANEDIOLPOWDERBULK INGREDIENT
-DAPAGLIFLOZIN PROPANEDIOLPOWDERBULK INGREDIENT
-DAPAGLIFLOZIN PROPANEDIOLPOWDERBULK INGREDIENT
-Dimethyl fumaratePOWDERBULK INGREDIENT
-ISOSORBIDE DINITRATE, DILUTEDPOWDERBULK INGREDIENT
-IvosidenibPOWDERBULK INGREDIENT
-OLAPARIBPOWDERBULK INGREDIENT
-OsimertinibPOWDERBULK INGREDIENT
-Sapropterin dihydrochloridePOWDERBULK INGREDIENT
-Selumetinib Hyd SulfatePOWDERBULK INGREDIENT
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.